Shumail Fatima, MD, MS
@ShumailFatima1
Alum @PittTweet & @PittICRE | Graduate @kemuofficial Opinions my own
Probably my 3rd or 4th time listening to @payalkohlimd and every time I learn something new @cvinnovations #CVI2025



More interventional heart failure at #CVI2025 @cvinnovations



Learning about hemodynamic monitoring in heart failure at CVI 2025 with the experts in the field: P.S. I found a nice contemporary review of some of the invasive and noninvasive devices currently available jscai.org/article/S2772-… @cvinnovations #CVI2025


South Asian data are absent in #ASCVD risk-derivation cohorts; Tasdighi et al. addressed this notable gap by describing sex-specific coronary artery calcium scores in an exclusively South Asian population. Read an expert analysis for more ➡️ bit.ly/4kQhAmF #cvPrev
Finerenone was effective in heart failure patients with mildly reduced or preserved ejection fraction, regardless of atrial fibrillation (AF) status, and new-onset AF was linked to higher risk of adverse outcomes. ja.ma/44IgNOA @HFpEF @AdriaanVoors @mvaduganathan
What's new in heart failure? June 2025 This month's newsletter highlights key updates in heart failure (HF) research, including congestion management, remote pulmonary artery pressure (PAP) monitoring, acute and advanced HF care, cardio-oncology, HF with mildly reduced and…
Diastology guideline update from @ASE360: clear flow charts, new subgroup algorithms, HFpEF dx Recommendations for the Evaluation of LV Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction: An Update From @ASE360 onlinejase.com/article/S0894-…
The American Heart Association's PREVENT equations accurately predicted CVD, ASCVD, and heart failure events across diverse Asian and Hispanic patient populations. ja.ma/4lpsUXA
Wildfire smoke air pollution is more strongly associated with HF risk. Important implications for threshold definitions and policymaking
Long-term exposure to #wildfire smoke-related fine particulate matter was linked to a higher risk of HF in older adults compared with non-wildfire smoke PM2.5. Furthermore, women & socially vulnerable populations were more susceptible. jacc.org/doi/10.1016/j.… #JACC #AirPollution
New JACC/ACC performance measures tighten LDL targets to <55 mg/dL for high-risk ASCVD—pushing earlier and more aggressive lipid management. Will this shift change clinician behavior in real-world prevention? Can we overcome existing inertia? jacc.org/doi/10.1016/j.…
Heart failure with preserved ejection fraction therapeutics: in search of the pillars transformative era in HFpEF management, with multiple landmark clinical trials demonstrating benefits for novel therapeutic classes : SGLT2i , Ns-MRAs, GLP-1a link.springer.com/article/10.100…
Heart Failure With Improved Ejection Fraction: Definitions, Epidemiology, and Management HFimpEF remains relatively understudied, and uncertainty persists regarding its long-term prognosis and optimal management jacc.org/doi/abs/10.101…
Enjoying Dr. @MeaganWasfy's talk on CPET Interpretation? Don’t miss this insightful review she co-authored in #JACC. It offers practical guidance for integrating 📊 from consumer wearable devices into CV clinical care. 🔗 bit.ly/3FSjLYk #ACCAthleticHeart @JACCJournals
#ACCEd: Baroreflex Activation Therapy (BAT): Optimizing Treatment of HF Learn to recognize the stages of HF where BAT will be most effective, as well as benefits and limitations for early intervention. 👇 Check out the infographic & learn more: bit.ly/3FhEoMO
CABANA trial: Patients who undergo catheter ablation for #AFib who also have #HFpEF experienced a greater benefit from ablation in terms of clinical outcome, AFib recurrence & functional status. Read more: bit.ly/43Zjj4j #JACCHF @JACCJournals #HeartFailure
The FRESH-UP study demonstrated that for patients with chronic #HeartFailure, liberal fluid intake did not result in a significant difference in health status vs. fluid restriction up to 1500 mL per day, and lowered perceived thirst distress. More: bit.ly/42qDQ0g #ACC25
Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock #ACC25 Routine early IABP plus standard care, compared with standard care, did not significantly improve survival or successful bridging to HRT in patients with HF-CS jacc.org/doi/10.1016/j.…
First day at #ACC25, here are the results of 10 trials presented today. I counted 3 NEJM, 1 Lancet, and 1 JAMA. WARRIOR: Intensive medical therapy did not reduce major CV events at five years in women with suspected INOCA. STRIDE: Semaglutide improved walking distance, symptoms,…
DAPA-TAVI: The #SGLT2 inhibitor dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening #HeartFailure in older adults w/ #vhdAS undergoing TAVI, resulting in a 28% relative risk ↘️. #ACC25 More: bit.ly/3DOlxJ8 #cvSurg
#ACC2025 LBCT 🚨 The SOUL trial delivers big for #semaglutide again! ✅ Oral semaglutide reduces ↓ MACE in T2DM + ASCVD/CKD (n=9,650) ✅ HR 0.86 | ARR 2% over 3 yrs | NNT = 50 📉 Improves HbA1c, weight, and inflammation 📖 Simultaneous publication in NEJM